Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 35Terminated 11Active not recruiting 7Unknown 5Withdrawn 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Gastrointestinal Neoplasms 1Adult Patients Who Are Receiving Oncologic Care 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Pharmacogenomic Testing × Clear all
NCT06511401 2026-05-04

C-PAIN

University of Chicago

Phase NA Recruiting
800 enrolled

Adult Patients Who Are Receiving Oncologic Care

NCT06489041 2026-02-02

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Wake Forest University Health Sciences

Phase NA Recruiting
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡